BioCentury
ARTICLE | Company News

Proteonomix dermatology, cardiovascular, gene/cell therapy news

June 27, 2011 7:00 AM UTC

At March 31, Proteonomix reported $925 in cash and a three-month operating loss of $280,097. ...